HealthCor Management’s Thermo Fisher Scientific TMO Stock Holding History

HealthCor Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-51,240	Closed	-$26M	–	54
2022 Q3	$26M	Buy	+51,240	New	+$28.7M	3.25%	10
2021 Q3	–	Sell	-182,970	Closed	-$92.3M	–	86
2021 Q2	$92.3M	Buy	+182,970	New	+$86.3M	3.69%	10
2020 Q3	–	Sell	-152,180	Closed	-$55.1M	–	57
2020 Q2	$55.1M	Buy	152,180 +92,180	+154%	+$30.9M	2.31%	22
2020 Q1	$17M	Buy	+60,000	New	+$18.9M	0.73%	34
2019 Q2	–	Sell	-157,520	Closed	-$43.1M	–	65
2019 Q1	$43.1M	Buy	+157,520	New	+$39.2M	1.74%	23
2018 Q3	–	Sell	-550,000	Closed	-$114M	–	55
2018 Q2	$114M	Buy	+550,000	New	+$117M	3.62%	8
2017 Q1	–	Sell	-94,980	Closed	-$13.4M	–	47
2016 Q4	$13.4M	Buy	+94,980	New	+$14M	0.76%	30
2016 Q3	–	Sell	-233,245	Closed	-$34.5M	–	50
2016 Q2	$34.5M	Sell	233,245 -141,755	-38%	-$20.9M	1.88%	18
2016 Q1	$53.1M	Buy	+375,000	New	+$50.3M	3.01%	13
2015 Q3	–	Sell	-23,480	Closed	-$3.05M	–	60
2015 Q2	$3.05M	Sell	23,480 -44,620	-66%	-$5.82M	0.15%	46
2015 Q1	$9.15M	Sell	68,100 -331,900	-83%	-$42.8M	0.44%	48
2014 Q4	$50.1M	Buy	400,000 +344,700	+623%	+$41.9M	2.79%	12
2014 Q3	$6.73M	Buy	+55,300	New	+$6.72M	0.35%	39
2014 Q1	–	Sell	-26,500	Closed	-$2.95M	–	69
2013 Q4	$2.95M	Sell	26,500 -14,426	-35%	-$1.43M	0.18%	47
2013 Q3	$3.77M	Buy	+40,926	New	+$3.7M	0.2%	54

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HealthCor Management's TMO Position: Q4 2022 in Review

HealthCor Management sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 51,240 shares — an estimated $26M sold.

HealthCor Management first reported a position in TMO in Q3 2013 and held it in 15 quarters. The position peaked at $114M in Q2 2018. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

HealthCor Management reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 51,240 Thermo Fisher Scientific shares in Q4 2022, an estimated $26M.
HealthCor Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 15 quarters.
HealthCor Management's Thermo Fisher Scientific position peaked at $114M in Q2 2018.
2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.